Maitland ML, Sachdev JC, Sharma MR, Moreno V, et al. First-in-Human Study of PF-06647020 (Cofetuzumab Pelidotin), an Antibody-Drug Conjugate Targeting Protein Tyrosine Kinase 7, in Advanced Solid Tumors. Clin Cancer Res 2021;27:4511-4520.
PMID: 34083232